CSPG4 and neoplasm: Using this approach, the elimination of antigen-negative solid tumor cells could be shown in vitro and in vivo rendering CSPG4-specific TRUCKs attractive for engaging tumor cells remaining CSPG4-negative after decitabine treatment [29].